导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 18.55% | 233/1050 |
| 近一周 | -0.34% | 340/1104 |
| 近一月 | -1.43% | 283/1103 |
| 近一季 | -14.68% | 854/1092 |
| 近半年 | 15.41% | 206/1070 |
| 近一年 | 32.33% | 159/1018 |
| 近两年 | 141.66% | 118/926 |
| 近三年 | 107.71% | 90/834 |
| 成立以来 | 152.52% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.63% 749/1070 |
52.64% 220/1101 |
- - |
- - |
| 2025 | 47.66% 220/1065 |
3.52% 513/1014 |
-1.11% 781/1038 |
40.61% 182/1050 |
2.58% 268/1065 |
| 2024 | 26.98% 37/1011 |
-0.20% 329/960 |
3.53% 140/983 |
9.91% 624/991 |
11.82% 54/1011 |
| 2023 | -21.88% 718/952 |
-2.51% 734/880 |
-2.16% 312/895 |
-13.49% 739/915 |
-5.34% 543/952 |
| 2022 | -29.24% 606/867 |
-17.99% 425/773 |
0.80% 681/806 |
-10.25% 256/845 |
-4.63% 629/867 |
| 2021 | 9.45% 256/740 |
-3.78% 292/580 |
17.17% 205/659 |
-0.62% 223/704 |
-2.31% 525/740 |
| 2020 | 56.30% 211/554 |
-10.42% 384/419 |
24.93% 194/466 |
10.47% 240/517 |
26.42% 57/554 |
| 2019 | 48.93% 157/410 |
23.60% 806/1149 |
8.38% 20/1231 |
4.24% 217/390 |
6.66% 290/410 |
| 2018 | - - |
- - |
- - |
- - |
-6.34% 89/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏潜龙精选股票 VS. 东吴新产业精选股票A(580008) |